Abcuro Competitors and Similar CompaniesClear all

Abcuro's competitors and similar companies include Neogene Therapeutics.
Abcuro
Abcuro
Abcuro is a company developing immunotherapies to treat autoimmunity and cancer.
Neogene Therapeutics
Neogene Therapeutics
Neogene Therapeutics is a pre-clinical stage biotechnology company that develops a new class of personalized T cell therapies to treat cancer.
Founding Date
Founding Date
2015
Founding Date
2018
Type
Type
Private
Type
Private
Tags
Locations
Locations
Newton, US HQ
Locations
New York, US HQ
Amsterdam, NL
Employees
Employees
514% increase
Employees
191

Funding

Latest funding round
Latest funding round
$ 8m (over 7 years ago)
Latest funding round
$ 110m (almost 6 years ago)
Total funding raised
Total funding raised
$ 10.3m
Total funding raised
$ 110m
For sources of this data, please see the company profile

View Company Profiles

Neogene Therapeutics
HQ
New York, US
Employees
191

Neogene Therapeutics is a pre-clinical stage biotechnology company that develops a new class of personalized T cell therapies to treat cancer.

View company